Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Cjc 1295 Dac Benefits

SKU CJ004 Original price $50.00 Sale price $45.00 CJC-1295 DAC 5mg Long-Acting Growth Hormone Releasing Hormone (GHRH) Analog – Research Grade Peptide CJC-1295 DAC 5mg is a synthetic growth hormone–releasing hormone (GHRH) analog engineered for extended half-life and sustained activity in laboratory research models. Designed with Drug Affinity Complex (DAC®) technology, this modified peptide binds to albumin in research systems, allowing prolonged circulation time compared to non-DAC variants. This 5mg lyophilized peptide format is ideal for controlled laboratory studies exploring growth hormone signaling pathways, IGF-1 modulation mechanisms, pulsatile GH release patterns, and endocrine research applications. What Is CJC-1295 DAC? CJC-1295 DAC is a tetrasubstituted analog of growth hormone–releasing hormone (GHRH 1-29). The DAC modification enables reversible binding to serum albumin in research models, extending its half-life significantly beyond standard GHRH peptides. Researchers c

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

SKU CJ004

Original price

$50.00

Sale price

$45.00

CJC-1295 DAC 5mg

Long-Acting Growth Hormone Releasing Hormone (GHRH) Analog – Research Grade Peptide

CJC-1295 DAC 5mg is a synthetic growth hormone–releasing hormone (GHRH) analog engineered for extended half-life and sustained activity in laboratory research models. Designed with Drug Affinity Complex (DAC®) technology, this modified peptide binds to albumin in research systems, allowing prolonged circulation time compared to non-DAC variants.

This 5mg lyophilized peptide format is ideal for controlled laboratory studies exploring growth hormone signaling pathways, IGF-1 modulation mechanisms, pulsatile GH release patterns, and endocrine research applications.

What Is CJC-1295 DAC?

CJC-1295 DAC is a tetrasubstituted analog of growth hormone–releasing hormone (GHRH 1-29). The DAC modification enables reversible binding to serum albumin in research models, extending its half-life significantly beyond standard GHRH peptides.

Researchers commonly investigate CJC-1295 DAC for:

Growth hormone release stimulation mechanisms

IGF-1 signaling pathway analysis

Endocrine system regulation studies

Anabolic signaling research models

Long-acting GHRH analog comparisons

Key Research Features

Compound: CJC-1295 DAC

Purity: High-purity research grade

Format: Lyophilized powder

Quantity: 5mg per vial

Stability: Designed for extended half-life research

Storage: Recommended refrigerated storage upon receipt

Each vial undergoes quality control testing to ensure consistency and integrity for laboratory applications.

CJC-1295 DAC vs. CJC-1295 (No DAC)

Feature CJC-1295 DAC CJC-1295 (No DAC) Half-Life (Research Models) Extended (multi-day) Shorter (hours) Albumin Binding Yes No Release Pattern Sustained Pulsatile Study Design Less frequent administration More frequent dosing

Important Notice

This product is intended strictly for laboratory research use only. Not for human consumption. Not for medical, veterinary, or therapeutic use.

By purchasing, researchers acknowledge compliance with all applicable regulations regarding research compounds.

Dosage

Pack Size

Quantity

CJC 1295 Compound

Compound CID: 91971820

MF: C165H269N47O46

MW: 3647.2 g/mol

IUPAC Name: (3S)-4-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-4-oxobutanoic acid

SMILES: CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=O)CCN3C(=O)C=CC3=O)C(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N

InChIKey: ZUQGTWKGESAQCD-ZGFIGYLBSA-N

InChI: InChI=1S/C165H269N47O46/c1-22-87(15)130(209-137(233)92(20)185-148(244)116(76-127(225)226)196-136(232)89(17)183-138(234)99(168)73-95-44-48-97(217)49-45-95)160(256)204-115(74-94-36-25-24-26-37-94)154(250)211-132(93(21)216)162(258)195-108(54-57-123(171)221)145(241)205-120(80-215)158(254)200-114(75-96-46-50-98(218)51-47-96)153(249)192-105(43-35-66-182-165(177)178)141(237)191-102(40-28-31-62-167)146(242)208-129(86(13)14)159(255)202-109(68-81(3)4)147(243)184-90(18)135(231)189-106(52-55-121(169)219)143(239)198-112(71-84(9)10)151(247)206-118(78-213)156(252)186-91(19)134(230)188-103(41-33-64-180-163(173)174)140(236)190-101(39-27-30-61-166)142(238)197-111(70-83(7)8)150(246)199-110(69-82(5)6)149(245)194-107(53-56-122(170)220)144(240)201-117(77-128(227)228)155(251)210-131(88(16)23-2)161(257)203-113(72-85(11)12)152(248)207-119(79-214)157(253)193-104(42-34-65-181-164(175)176)139(235)187-100(133(172)229)38-29-32-63-179-124(222)60-67-212-125(223)58-59-126(212)224/h24-26,36-37,44-51,58-59,81-93,99-120,129-132,213-218H,22-23,27-35,38-43,52-57,60-80,166-168H2,1-21H3,(H2,169,219)(H2,170,220)(H2,171,221)(H2,172,229)(H,179,222)(H,183,234)(H,184,243)(H,185,244)(H,186,252)(H,187,235)(H,188,230)(H,189,231)(H,190,236)(H,191,237)(H,192,249)(H,193,253)(H,194,245)(H,195,258)(H,196,232)(H,197,238)(H,198,239)(H,199,246)(H,200,254)(H,201,240)(H,202,255)(H,203,257)(H,204,256)(H,205,241)(H,206,247)(H,207,248)(H,208,242)(H,209,233)(H,210,251)(H,211,250)(H,225,226)(H,227,228)(H4,173,174,180)(H4,175,176,181)(H4,177,178,182)/t87-,88-,89+,90-,91-,92-,93+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,129-,130-,131-,132-/m0/s1

Create Date: 2015-11-02

CJC 1295 DAC Certificate of Analysis

3rd-Party Lab Tested

Every batch is independently tested for purity and quality.

≥99% Purity Guarantee

Our peptides meet or exceed research-grade standards.

Fast U.S. Shipping

Orders ship quickly and discreetly from U.S. warehouses.

Research-Use Only

Properly labeled and handled for licensed research use.

Connected topics

Follow this recovery question